Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1 - Janssen, Maike; Schmidt, Christina; Bruch, Peter-Martin; Blank, Maximilian Felix; Rohde, Christian; Waclawiczek, Alexander; Heid, Daniel; Renders, Simon; Göllner, Stefanie; Vierbaum, Lisa; Besenbeck, Birgit; Herbst, Sophie; et al. (Blood, 2022)
Gesehen am 21.12.2023